Arthur A. Serpick

2.7k total citations · 1 hit paper
49 papers, 2.1k citations indexed

About

Arthur A. Serpick is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Arthur A. Serpick has authored 49 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 10 papers in Genetics. Recurrent topics in Arthur A. Serpick's work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Arthur A. Serpick is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Arthur A. Serpick collaborates with scholars based in United States, Malaysia and India. Arthur A. Serpick's co-authors include Peter H. Wiernik, Stephen C. Schimpff, Viola Mae Young, W. Satterlee, Jerome B. Block, Stanley Lowenbraun, Vincent T. DeVita, Paul P. Carbone, George P. Canellos and Charles M. Haskell and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Arthur A. Serpick

47 papers receiving 1.7k citations

Hit Papers

Empiric Therapy with Carbenicillin and Gentamicin for Feb... 1971 2026 1989 2007 1971 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arthur A. Serpick United States 23 863 393 363 345 291 49 2.1k
G Lundgren Sweden 29 608 0.7× 320 0.8× 311 0.9× 378 1.1× 319 1.1× 142 3.3k
Francesco Perfumo Italy 32 676 0.8× 209 0.5× 357 1.0× 135 0.4× 684 2.4× 145 3.6k
Isaac Djerassi United States 22 470 0.5× 424 1.1× 197 0.5× 210 0.6× 149 0.5× 38 1.3k
L Morel-Marogér France 33 237 0.3× 373 0.9× 543 1.5× 204 0.6× 719 2.5× 131 3.1k
Gudrun Fleischhack Germany 28 561 0.7× 522 1.3× 348 1.0× 482 1.4× 589 2.0× 101 2.5k
A. G. R. Sheil Australia 26 430 0.5× 126 0.3× 332 0.9× 288 0.8× 148 0.5× 130 2.6k
Victoriano Pardo United States 26 195 0.2× 201 0.5× 288 0.8× 115 0.3× 391 1.3× 66 3.0k
Jiro Inagaki Japan 19 451 0.5× 496 1.3× 204 0.6× 209 0.6× 188 0.6× 90 1.5k
John P. Whitecar United States 13 334 0.4× 213 0.5× 208 0.6× 271 0.8× 168 0.6× 18 977
Josette Eris Australia 29 613 0.7× 117 0.3× 213 0.6× 340 1.0× 621 2.1× 56 3.6k

Countries citing papers authored by Arthur A. Serpick

Since Specialization
Citations

This map shows the geographic impact of Arthur A. Serpick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur A. Serpick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur A. Serpick more than expected).

Fields of papers citing papers by Arthur A. Serpick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur A. Serpick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur A. Serpick. The network helps show where Arthur A. Serpick may publish in the future.

Co-authorship network of co-authors of Arthur A. Serpick

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur A. Serpick. A scholar is included among the top collaborators of Arthur A. Serpick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur A. Serpick. Arthur A. Serpick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serpick, Arthur A.. (1984). Soft tissue and bone sarcomas. Journal of the American Podiatric Medical Association. 74(7). 355–358. 1 indexed citations
2.
Riggs, Charles E., Robert S. Benjamin, Arthur A. Serpick, & Nicholas R. Bachur. (1977). Biliary disposition of adriamycin. Clinical Pharmacology & Therapeutics. 22(2). 234–241. 78 indexed citations
3.
Alberts, David S., et al.. (1975). Hypocalcemia complicating acute leukemia. Medical and Pediatric Oncology. 1(3). 289–295. 6 indexed citations
4.
Steele, Thomas H., Arthur A. Serpick, & Jerome B. Block. (1973). ANTIDIURETIC RESPONSE TO CYCLOPHOSPHAMIDE IN MAN. Journal of Pharmacology and Experimental Therapeutics. 185(2). 245–253. 46 indexed citations
5.
Serpick, Arthur A., et al.. (1973). Water Intoxication and Cyclophosphamide. Annals of Internal Medicine. 79(5). 763–764.
6.
Brace, Kirkland C., Arthur A. Serpick, Jerome B. Block, & P H Wiernik. (1973). Combination Radiotherapy and Chemotherapy in the Treatment of Early Hodgkin’s Disease. Oncology. 27(6). 484–492. 12 indexed citations
7.
Presant, Cary A., Peter H. Wiernik, & Arthur A. Serpick. (1973). Factors affecting survival in nocardiosis.. PubMed. 108(6). 1444–8. 8 indexed citations
8.
Wiernik, Peter H. & Arthur A. Serpick. (1972). A randomized clinical trial of daunorubicin and a combination of prednisone, vincristine, 6-mercaptopurine, and methotrexate in adult acute nonlymphocytic leukemia.. PubMed. 32(10). 2023–6. 56 indexed citations
9.
Young, Robert C., Vincent T. DeVita, Arthur A. Serpick, & George P. Canellos. (1971). Treatment of Advanced Hodgkin’s Disease with [1,3 Bis (2-Chloroethyl)-1-Nitrosourea] BCNU. New England Journal of Medicine. 285(9). 475–479. 43 indexed citations
10.
Mendelson, David S., Jerome B. Block, & Arthur A. Serpick. (1970). Effect of large intermittent intravenous doses of cyclophosphamide in lymphoma. Cancer. 25(3). 715–720. 23 indexed citations
11.
Lowenbraun, Stanley, Vincent T. DeVita, & Arthur A. Serpick. (1970). Combination Chemotherapy With Nitrogen Mustard, Vincristine, Procarbazine and Prednisone in Previously Treated Patients With Hodgkin’s Disease. Blood. 36(6). 704–717. 54 indexed citations
12.
Wiernik, Peter H. & Arthur A. Serpick. (1970). Granulocytic Sarcoma (Chloroma). Blood. 35(3). 361–369. 199 indexed citations
13.
Mitch, William E. & Arthur A. Serpick. (1970). Leukemic infiltration of the prostate: A reversible form of urinary obstruction. Cancer. 26(6). 1361–1365. 14 indexed citations
14.
Wiernik, Peter H. & Arthur A. Serpick. (1970). FACTORS EFFECTING REMISSION AND SURVIVAL IN ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL). Medicine. 49(6). 505–505. 80 indexed citations
15.
Slater, Lewis M., Robert Wainer, & Arthur A. Serpick. (1969). Vincristine neurotoxicity with hyponatremia. Cancer. 23(1). 122–125. 47 indexed citations
16.
Haskell, Charles M., George P. Canellos, B. G. Leventhal, et al.. (1969). L-asparaginase toxicity.. PubMed. 29(4). 974–5. 65 indexed citations
17.
Serpick, Arthur A., et al.. (1969). Metastatic hemangiopericytoma treated with vincristine and actinomycin D. Cancer. 24(2). 266–269. 31 indexed citations
18.
Serpick, Arthur A., et al.. (1968). Antipyretic effect of indomethacin in patients with malignancy. Cancer. 21(4). 781–786. 15 indexed citations
19.
Burke, Philip J., et al.. (1968). A clinical evaluation of dose and schedule of administration of cytosine arabinoside (NSC 63878).. PubMed. 28(2). 274–9. 25 indexed citations
20.
Serpick, Arthur A. & E. S. Henderson. (1967). Observations on toxicity and clinical trials with daunomycin.. PubMed. 15(19). 909–12. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026